By Kamal Choudhury and Christy Santhosh
(Reuters) -The U.S. Food and Drug Administration on Thursday approved Kura Oncology and Japanese partner Kyowa Kirin's once-daily pill, Komzifti, to treat a rare form of blood cancer that has returned or stopped responding to treatment.
The drug is approved for acute myeloid leukemia patients with an NPM1 mutation, a genetic change found in about 30% of cases.
Acute myeloid leukemia is an aggressive cancer of the blood and bone marrow.
Kura said the drug will be available within the next few business days at a price of $48,500 for a one-month supply.
With the approval, Kura's drug now competes with Syndax Pharmaceuticals' Revuforj, which was approved for the same indication by the FDA last month.
Komzifti’s approval comes with a boxed warning for differentiation syndrome and an additional warning for QTc interval prolongation, a delay in the heart’s electrical recovery after a beat, and potential harm to unborn babies.
A boxed warning is the U.S. Food and Drug Administration’s strongest alert for serious or life-threatening risks and appears prominently on a drug’s label to warn doctors and patients.
Revuforj carries a boxed warning for QTc interval prolongation, giving Kura “a significant competitive advantage,” according to Wedbush analysts.
Kura's Chief Medical Officer Mollie Leoni said the risk of QTc prolongation with Komzifti is low, adding it is “extraordinarily unlikely” to lead to a boxed warning.
The company said it is in dialogue with the FDA about potential steps post-approval that could help refine the labeling.
Under the terms of its collaboration with Kyowa, Kura is responsible for manufacturing Komzifti and will lead commercialization in the United States, while Kyowa handles commercial strategy and development outside the U.S.
Analysts, on average, expect Komzifti to have annual sales of $1.32 billion by 2031, according to LSEG data.
(Reporting by Kamal Choudhury and Christy Santhosh in Bengaluru; Editing by Shailesh Kuber and Tasim Zahid)
LATEST POSTS
- 1
The Delight of Perusing: Book Proposals for Each Class - 2AI is providing emotional support for employees – but is it a valuable tool or privacy threat?
- 3Figure out How to Utilize Your Web based Advertising Degree to Break into the Tech Business
- 4The most effective method to Safeguard Your Teeth from Acidic Food varieties and Beverages
- 5Chevron Says Damage at Wheatstone LNG Will Hamper Restart
- Land Rover Just Unveiled Its Dakar Rally Defender
- A Lone Wolf Outsmarted Hunters in the Black Forest and Then Vanished
- Most loved Well known Accessory Styles For 2024
- The most effective method to Use an Internet Showcasing Degree for Advanced Predominance
- Gov’t approves millions for border cities in North under Hezbollah fire
- How to identify animal tracks, burrows and other signs of wildlife in your neighborhood
- The Job of Attorneys: It is Important to Comprehend When Legitimate Help
- Russia patents space station designed to generate artificial gravity
- Argentina joins NASA’s moon return with microsatellite testing GPS beyond Earth
